This review will discuss issues arising along with the expanding use of hypomethylating treatment (HMT) in the management of acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS).
Voso, M.t., LO COCO, F., Fianchi, L. (2015). Epigenetic therapy of myelodysplastic syndromes and acute myeloid leukemia. CURRENT OPINION IN ONCOLOGY, 27(6), 532-539 [10.1097/CCO.0000000000000231].
Epigenetic therapy of myelodysplastic syndromes and acute myeloid leukemia
VOSO, MARIA TERESA;LO COCO, FRANCESCO;
2015-11-01
Abstract
This review will discuss issues arising along with the expanding use of hypomethylating treatment (HMT) in the management of acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
